Page last updated: 2024-08-23

silybin and Colitis

silybin has been researched along with Colitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, H; Dong, W; Liu, L; Liu, T; Ma, J; Wang, B; Wang, D; Wang, S; Xie, R; Zheng, R1
Han, W; Li, W; Lv, X; Wang, H; Zhao, X1
Khaleghi, N; Minaiyan, M; Varshosaz, J1
Abdollahi, M; Baeeri, M; Esmaily, H; Miroliaee, AE; Vaziri-Bami, A1

Other Studies

4 other study(ies) available for silybin and Colitis

ArticleYear
Chemopreventive Effects of Silibinin on Colitis-Associated Tumorigenesis by Inhibiting IL-6/STAT3 Signaling Pathway.
    Mediators of inflammation, 2018, Volume: 2018

    Topics: Animals; Azoxymethane; Blotting, Western; Colitis; Colonic Neoplasms; Dextran Sulfate; Female; HCT116 Cells; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-6; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Silybin; STAT3 Transcription Factor

2018
Silibinin Retards Colitis-associated Carcinogenesis by Repression of Cdc25C in Mouse Model.
    Inflammatory bowel diseases, 2019, 06-18, Volume: 25, Issue:7

    Topics: Animals; Antineoplastic Agents, Phytogenic; Azoxymethane; Carcinogenesis; Carcinogens; cdc25 Phosphatases; Colitis; Colonic Neoplasms; Dextran Sulfate; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Male; Mice; Mice, Inbred C57BL; Silybin

2019
Eudragit nanoparticles loaded with silybin: a detailed study of preparation, freeze-drying condition and in vitro/in vivo evaluation.
    Journal of microencapsulation, 2015, Volume: 32, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Colitis; Colon; Dexamethasone; Drug Carriers; Freeze Drying; Inflammation; Interleukin-6; Male; Nanoparticles; Peroxidase; Polymethacrylic Acids; Rats, Wistar; Silybin; Silybum marianum; Silymarin; Tumor Necrosis Factor-alpha

2015
The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
    Fundamental & clinical pharmacology, 2011, Volume: 25, Issue:6

    Topics: Animals; Antioxidants; Cholagogues and Choleretics; Colitis; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Male; NF-kappa B; Rats; Rats, Wistar; Silybin; Silymarin; Trinitrobenzenesulfonic Acid; Ursodeoxycholic Acid

2011